Free CME from PeerView


Oncology CME

PVI, PeerView Institute for Medical Education
New Horizons for Advanced Endometrial Cancer Treatment: Utilizing Innovative Immunotherapies and Other Novel Approaches
February 06, 2023
PVI, PeerView Institute for Medical Education
Innovation Now for Follicular Lymphoma: New Evidence for Immunotherapy, Targeted, and Chemo-Free Options
February 01, 2023
PVI, PeerView Institute for Medical Education
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
February 01, 2023
PVI, PeerView Institute for Medical Education
Fine-Tuning Biomarker Testing to Identify and Target RET Fusions as Uncommon But Actionable Genomic Alterations in NSCLC
January 29, 2023
PVI, PeerView Institute for Medical Education
Getting Personal With Advanced BTC: Insights on Personalizing Upfront and Sequential Care With Immunotherapy and Targeted Agents
January 20, 2023
PVI, PeerView Institute for Medical Education
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How to Modernize Best Practices Based on New Evidence and Better Multidisciplinary Alliances
January 20, 2023
PVI, PeerView Institute for Medical Education
The HCC Revolution Continues: Exploring Evidence-Based Treatment Selection and Sequencing in Advanced Disease and Beyond
January 19, 2023
PVI, PeerView Institute for Medical Education
Changing Times for Hemophilia: Exploring Evidence With Novel and Emerging Nonfactor Therapies
December 29, 2022
Medical Learning Institute, Inc.
New Evidence Now for Targeted Therapy in TGCT
December 22, 2022
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
December 15, 2022
Penn State College of Medicine
Real-World, Real Innovation in DLBCL: Perspectives on Integrating Novel Antibody Platforms Into Patient Care
December 08, 2022
Medical Learning Institute, Inc.
Demystifying Cold Agglutinin Disease: A Visual Exploration of Mechanism, Diagnosis, and the Role of Complement Inhibition in Addressing Unmet Needs
December 08, 2022
PSU, Penn State University
Fixing the Target on Aggressive Lymphoma: Guidance on the Next Phase of Integrating Targeted Agents Into MCL and DLBCL Management
December 08, 2022
PSU, Penn State University
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
December 08, 2022
PVI, PeerView Institute for Medical Education
Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer
December 06, 2022
PVI, PeerView Institute for Medical Education
On the Cusp of Change: Modernizing the Treatment of Desmoid Tumors With Novel Gamma Secretase Inhibitors
November 29, 2022
PVI, PeerView Institute for Medical Education
Case by Case: Maximizing Personalized Approaches to Prostate Cancer
November 29, 2022
PVI, PeerView Institute for Medical Education
Personalizing Bladder Cancer Care in the Modern Therapeutic Era: One Size No Longer Fits All
November 29, 2022
PVI, PeerView Institute for Medical Education
Don’t Miss the Rare When Diagnosing and Treating Autoimmune Hemolytic Anemia: Focus on CAD
November 08, 2022
Medical Learning Institute, Inc.
It Takes a Team for HCC: Improving Outcomes Through Multidisciplinary Collaboration & Modern Therapeutics
November 04, 2022

Pages